Literature DB >> 6512699

Comparison of effect of peptide length and sulphation on acid secretory potency of gastrin in the cat in vivo and in vitro.

B H Hirst, J Holland, A P Marr, M E Parsons, D J Sanders.   

Abstract

The gastric-acid secretory potency of gastrin peptides was investigated in vivo, in conscious cats prepared with gastric fistula, and in vitro, with kitten isolated gastric mucosae. The influence of peptide length on potency was investigated by comparing synthetic human gastrin heptadecapeptide, non-sulphate (shG17ns) with a synthetic gastrin butyloxycarbonyl hexapeptide (G6ns), and the influence of sulphation by comparison of G6ns with its sister sulphated peptide (G6s). When exogenous doses were compared, shG17ns was the most potent peptide (mean exogenous dose for half-maximal stimulation (EDe50) : 0.33 nmol kg-1 h-1), and was 15.8 times more potent than G6ns (EDe50:5.14 nmol kg-1 h-1). This potency ratio was reduced to 9.4 when circulating immunoreactive concentrations of the two peptides were compared (mean circulating concentration for half-maximal stimulation (EDc50) : shG17ns, 201 pM; G6ns, 1890 pM). The greater potency ratio when exogenous doses were compared was due to the greater metabolic clearance rate (m.c.r.) of the shorter gastrin (m.c.r.: shG17ns, 37 ml kg-1 min-1; G6ns, 121 ml kg-1 min-1). In vitro, shG17ns (mean concentration for half-maximal stimulation (EC50) : 1.99 nM) was 2.8 times more potent than G6ns (EC50: 5.57 nM). Sulphation of the hexapeptide increased its potency 3.6-fold when exogenous doses were compared (EDe50 G6s: 1.42 nmol kg-1 h-1). The greater potency of the sulphated peptide appeared to be due to its lower m.c.r. (20 ml kg-1 min-1), and was eliminated when circulating concentrations were compared; potency ratio G6ns: G6s, 1.1. We conclude that the increased potency of short gastrin peptides observed upon sulphation is likely to be due to increased resistance to metabolic clearance. Part of the increased potency observed with increasing peptide length can also be explained by increased resistance to clearance, but the small potency difference in vitro may reflect greater affinity for gastrin receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512699      PMCID: PMC1193268          DOI: 10.1113/jphysiol.1984.sp015510

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Clearance rate, half-life, and secretory potency of human gastrin-17-I in different species.

Authors:  J Boniface; D Picone; M Schebalin; A M Zfass; G M Makhlouf
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

2.  Pure human minigastrin: secretory potency and disappearance rate.

Authors:  H T Debas; J H Walsh; M I Grossman
Journal:  Gut       Date:  1974-09       Impact factor: 23.059

3.  Action of caerulein and caerulein-like peptides on "short-circuit current" and acid secretion in the isolated gastric mucosa of amphibians.

Authors:  L Negri; V Erspamer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  The metabolic clearance rate and half-life of synthetic human gastrin in dogs.

Authors:  E Schrumpf; L S Semb
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Synthetic peptides related to caerulein. 1.

Authors:  A Anastasi; L Bernardi; G Bertaccini; G Bosisio; R De Castiglione; V Erspamer; O Goffredo; M Impicciatore
Journal:  Experientia       Date:  1968-08-15

6.  The effect of sympathetic nerve stimulation on serum gastrin, gastric acid secretion and mucosal blood flow responses to meat extract stimulation in anaesthetized cats.

Authors:  E L Blair; E R Grund; J D Reed; D J Sanders; G Sanger; B Shaw
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

7.  Clearance and acid-stimulating action of human big and little gastrins in duodenal ulcer subjects.

Authors:  J H Walsh; J I Isenberg; J Ansfield; V Maxwell
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Histamine-stimulated hydrogen ion secretion by in vitro piglet gastric mucosa.

Authors:  J G Forte; T M Forte; T E Machen
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

9.  Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients.

Authors:  G J Dockray; J H Walsh
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

10.  Metabolic clearance and disappearance rates of synthetic human gastrin in man.

Authors:  E Schrumpf; L S Semb; H Vold
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

View more
  2 in total

1.  Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa.

Authors:  B H Hirst; J Holland; M E Parsons; C A Price
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Post-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanism.

Authors:  J F Rehfeld; C P Hansen; A H Johnsen
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.